Evidence map›Paper›PMID 41637047›Full record

ArticleJournal of fluorescence2026

Phosphorus-Nitrogen Co-doped Carbon Dots for Fluorescence Detection of Tigecycline: Mechanistic Exploration.

Qian Su, Li Huang, Youjin Zhang, Zhiyong Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qian SuClinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, 610041, China.
Li HuangClinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, 610041, China.
Youjin ZhangClinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, 610041, China.
Zhiyong YangClinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, 610041, China. 109872931@qq.com.

Funding

Sichuan Provincial Hospital Association young pharmacists research fund project YP2202436
6 · The paper itself

Abstract

Carbon dots (CDs) have been broadly employed in many fields due to their excellent fluorescence property, especially in pharmaceutical analysis. Herein, we developed a simple and rapid method to prepare the phosphorus-nitrogen (P, N) co-doped carbon dots via a 3-minute 50-second microwave-assisted synthesis, using N-butyldiethanolamine as the carbon source with phosphoric acid accelerating the CDs formation reaction. The prepared CDs (termed CD1) were characterized by TEM, FT-IR, XPS, XRD and fluorescence spectroscopy. P, N co-doped CDs exhibited notable water solubility, a quantum yield of 19.7% and good photobleaching resistance. Taking advantage of their superior fluorescence, these CDs served as a bright-blue probe for tigecycline detection through fluorescence quenching. The sensor displayed excellent selectivity and anti-interference ability against common coexisting drugs (e.g., voriconazole, ceftazidime, amikacin). Under optimized conditions, a wide linear range (1-936 µM) between F0/F and Tigecycline concentration was established, with a correlation coefficient (R) of 0.984, and the detection limit (LOD) was calculated to be 1.10 µM. Furthermore, we clarified the fluorescence quenching mechanism of CD1 toward tigecycline, which was attributed to the internal filtration effect (IFE). Thus, this work demonstrated a novel P, N co-doped CD-based sensing strategy for rapid tigecycline monitoring.

Indexed as

Anti-Bacterial AgentsCarbon Quantum DotsFluorescent DyesMinocyclineNitrogenPhosphorusTigecyclineCarbonFluorescenceFluorescent Chemosensor CompoundsSpectrometry, FluorescenceAnti-Bacterial AgentsCarbonFluorescent Chemosensor CompoundsFluorescent DyesMinocyclineNitrogenPhosphorusTigecyclineCarbon dotsPharmaceutical analysisQuenching mechanismTigecycline detection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.